Power-Up: An Effectiveness Trial of the Diabetes Prevention Program Tailored for Black and Latino Men

Information

  • Research Project
  • 10376657
  • ApplicationId
    10376657
  • Core Project Number
    R01DK121896
  • Full Project Number
    3R01DK121896-03S1
  • Serial Number
    121896
  • FOA Number
    PA-20-272
  • Sub Project Id
  • Project Start Date
    9/16/2019 - 4 years ago
  • Project End Date
    8/31/2024 - 3 months from now
  • Program Officer Name
    THORNTON, PAMELA L
  • Budget Start Date
    9/1/2021 - 2 years ago
  • Budget End Date
    8/31/2022 - a year ago
  • Fiscal Year
    2021
  • Support Year
    03
  • Suffix
    S1
  • Award Notice Date
    9/3/2021 - 2 years ago

Power-Up: An Effectiveness Trial of the Diabetes Prevention Program Tailored for Black and Latino Men

Abstract A clinic-based translation of the Diabetes Prevention Program (DPP) tailored to Black and Latino men has the potential to address prior limitations of DPP implementation and reduce diabetes disparities among men. The proposed study is designed to 1) Assess the effect of Power-Up vs. standard care National DPP (NDPP) on percent weight loss among racial/ethnic minority men at risk for diabetes; 2) Compare engagement of racial/ethnic minority men at risk for diabetes in Power-Up vs. standard care NDPP; and 3) Evaluate the Reach, Effectiveness, Adoption, Implementation, and Costs of Power-Up using the RE-AIM framework. We hypothesize that men randomized to Power-Up will achieve significantly greater weight loss (% weight loss from baseline) at 16-weeks and 1-year than men randomized to the standard care, mixed-gender NDPP group. Men randomized to Power-Up will also have significantly greater engagement rates (i.e., attend at least 4 sessions) and retention rates (i.e., attend 9 or more sessions) than men randomized to the standard care NDPP. Using the electronic health record (EHR) systems of a large academic medical center and a network of small to medium independent primary care practices throughout New York City, we will identify Black and Latino men that meet the BMI and A1c eligibility requirements for NDPP. We expect to enroll 450 participants through our health system partners. Men will be randomized 1:1 to either the Power-Up intervention arm or referred to the standard NDPP at their clinic site. Consistent with current CDC standards and current NDPP practices of our health system partners, telephone make-up sessions will be offered by coaches in both conditions to men who miss in-person sessions. The primary outcome will be percent weight loss over 12 months, measured at baseline, approximately 16 weeks (end of core sessions), and 12 months (end of maintenance sessions). Study-collected weight will be the primary outcome measured at the first Power-Up or NDPP session by coaches (or from study staff or clinic sites when sessions are not attended). With a sample size of 450 men, a standard deviation of 4.7 percentage points in percent weight loss, and an intraclass (intra program group) correlation of 0.05 we would have 98.2% power to detect a 2.5 percentage point difference between the intervention arms at the 0.05 significance level. This sample size would also give us 80% power to detect a 13.8 percentage point difference in engagement, and a 16.4 percentage point difference in retention. Tertiary outcomes related to the RE-AIM evaluation include quantitative and qualitative data collected via validated self- report questionnaires administered via telephone survey, EHR-data extraction, and qualitative interviewing of individuals and focus groups. Our evaluation will answer questions most important to healthcare systems and NDPP providers and our partnerships with diverse healthcare systems will allow us to disseminate the intervention broadly, if proven effective.

IC Name
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES
  • Activity
    R01
  • Administering IC
    DK
  • Application Type
    3
  • Direct Cost Amount
    83333
  • Indirect Cost Amount
    56666
  • Total Cost
    139999
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    847
  • Ed Inst. Type
  • Funding ICs
    NIDDK:139999\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    PRDP
  • Study Section Name
    Psychosocial Risk and Disease Prevention Study Section
  • Organization Name
    ALBERT EINSTEIN COLLEGE OF MEDICINE
  • Organization Department
  • Organization DUNS
    081266487
  • Organization City
    BRONX
  • Organization State
    NY
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    104611900
  • Organization District
    UNITED STATES